Oral

[O25-3] O25-3: Drug abuse

Mon. Sep 25, 2017 1:30 PM - 2:30 PM Room E (1F)

Chairs: Eric J.F. Franssen, The Netherlands / Ryuji Kato, Japan

+Add all to schedule

[O25-3-1] Evolution of drug abuse in drivers: a French retrospective analysis of about 9000 cases over a 13-year period

Franck Saint-Marcoux¹, Souleiman El Balkhi², Sylvain Dulaurent³ (1.Limoges University Hospital, 2.Limoges University Hospital, 3.Limoges University Hospital)

[O25-3-2] Evaluation of an Ion Trap LC-MS/MS insturment (Toxtyper) for drug of abuse screening in oral fluid

Maria Shipkova¹, Kevin Berbalk², Thomas Plecko³, Eberhard Wieland⁴ (1.Klinikum Stuttgart, 2.Klinikum Stuttgart, 3.Klinikum Stuttgart, 4.Klinikum Stuttgart)

[O25-3-3] A new bioassay for detection and activity profiling of synthetic opioids

Christophe Stove¹, Annelies Cannaert², Lakshmi Vasudevan³, Maurice Wilde⁴, Volker Auwaerter⁵, Kathleen Van Craenenbroeck⁶, Sarah Wille⁷, Christophe Stove⁸ (1.Ghent University, 2.Ghent University, 3.Ghent University, 4.University of Freiburg, 5.University of Freiburg, 6.Ghent University, 7.Federal Public Service Justice, National Institute of Criminalistics and Criminology, 8.Ghent University)

[O25-3-4] Direct and rapid analysis of drugs in serum by probe electrospray ionization tandem mass spectrometry (PESI/MS/MS)

Tomomi Ohara¹, Kei Zaitsu², Yumi Hayashi³, Maiko Kusano⁴, Kazuaki Hisatsune⁵, Tasuku Murata⁶, Stephane Moreau⁷, Hiroki Nakajima⁸, Hiroshi Tanihata⁹, Hitoshi Tsuchihashi¹⁰, Tetsuya Ishikawa¹¹, Akira Ishii¹² (1.Nagoya University, 2.Nagoya University, 3.Nagoya University, 4.Nagoya University, 5.Nagoya University, 6.Shimadzu Corporation, 7.Shimadzu Europa GmbH, 8.European Innovation Center, Shimadzu Europa GmbH, 9.Shimadzu Corporation, 10.Nagoya University, 11.Nagoya University, 12.Nagoya University)